• Results and Opportunities

    Results and Opportunities

    Publication captures results of GAVI support and sets out opportunities for the future.

    English | Français

  • Audio-visual updates

    26 January 2012

    GAVI’s Matching Fund announcement at WEF

    Supporters of GAVI’s Matching Fund met at the 2012 World Economic Forum to announce gifts of US$ 4.5m from  two new partners: Comic Relief and The Children’s Investment Fund Foundation (CIFF).

    26 January 2012

    Chad’s campaign against meningitis A

    One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.

    16 November 2011

    Laos' efforts to stop rubella and measles for good

    In November 2011, Laos is introducing rubella vaccine for the first time. During a two-phase campaign, Laos plans to immunise more than three million young people with the combined vaccine for measles and rubella ("MR" vaccine), offering protection against two preventable diseases.

    16 November 2011

    The toll of cervical cancer

    Approximately 275,000 women die every year from cervical cancer with 88% occurring in developing countries, but HPV vaccines offer protection against 70% of all cervical cancer cases.

  • Value of vaccination

    Vaccines are cost-effective, offer lifelong protection and are fundamental to development.

  • GAVI's impact

    GAVI's impact

    "The GAVI model" has pushed immunisation rates in low-income countries to historic levels.

close icon

modal window here